For early-stage cancers, DNA methylation-based biomarkers are of particular importance Recent scientific work indicates the high potential of hypermethylated genes TWIST1, VIM, ZNF671, OTX1, and IRF8 for early diagnosis and PTK2, AHNAK, and DAPK for BC prognosis. This evidence concerns the gene PTK2 and breast cancer.